Exact Mass: 744.241794
Exact Mass Matches: 744.241794
Found 71 metabolites which its exact mass value is equals to given mass value 744.241794
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
4-O-[6-acetoxy-beta-D-glucopyranosyl(1->2)-3,4-di-O-methyl-beta-D-xylopyranosyl]diphyllin|taxodiifoloside
(+)-lyoniresinol 2a-O-alpha-D-galactopyranosyl-3a-O-beta-D-glucopyranoside
(3R,4R)-2-hydroxy-3,4-bis(3,5-dimethoxy-4-beta-D-glucopyranosiloxybenzyl)tetrahydrofuran
(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-glucopyranoside|(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1[*]4)-beta-D-glucopyranoside
(+)-lyoniresinol 4,4-bis-O-beta-D-glucopyranoside|(-)-Lyoniresinol-4,4-bis-O-??-D-glucopyranoside
(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1?3)-beta-D-glucopyranoside|pteleifoside G
homoeriodictyol-7-O-beta-D-apiosyl-(1?5)-beta-D-apiosyl-(1?2)-beta-D-glucoside
(-)-(8R,7E)-4-hydroxy-3,3,5,5-tetramethoxy-8,4-oxyneolign-7-ene-9,9-diol 4,9-bis-O-beta-D-glucopyranoside
(+)-lyoniresinol 3a-O-alpha-D-galactopyranosyl-(1->6)-beta-D-glucopyranoside
(7S*,8R*,7S*,8R*)-huazhongilexin 9-O-(2-feruloyl)-beta-D-xylopyranoside
[3-hydroxy-3-[(4-hydroxyphenyl)methyl]-4-oxo-4-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butan-2-yl] 3-acetyloxy-2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanoate
2-[[5-chloro-4-[2-chloro-4-[[1-(2,4-dimethylanilino)-1,3-dioxobutan-2-yl]diazenyl]-5-methoxyphenyl]-2-methoxyphenyl]diazenyl]-N-(2,4-dimethylphenyl)-3-oxobutanamide
6-methylheptyl 2-[methyl-bis[[2-(6-methylheptoxy)-2-oxoethyl]sulfanyl]stannyl]sulfanylacetate
C31H60O6S3Sn (744.2573809999999)
2,7-dimethoxy-3,6-bis(12-bromododecylthio)-naphthalene
C36H58Br2O2S2 (744.2244728000001)
Orvepitant maleate
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Orvepitant maleate (GW823296 maleate) is potent, selective, orally active and well-tolerated neurokinin-1 receptor (NK-1) antagonist with a pKi of 10.2 for human neurokinin-1 receptor. Orvepitant maleate can across the blood-brain barrier. Orvepitant maleate has the potential for depressive disorder and chronic refractory cough (CRC) treatment[1][2].
(+)-lyoniresinol 4,4-bis-O-beta-D-glucopyranoside
A lignan that consists of (+)-lyoniresinol attached to two beta-D-glucopyranosyl units at positions 4 and 4 via glycosidic linkages. Isolated from Indigofera heterantha, it exhibits inhibitory activity against lipoxygenase.
3,4,5-trihydroxy-6-[3-[(E)-2-[2-hydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxy]oxane-2-carboxylic acid
[3-Hydroxy-3-[(4-hydroxyphenyl)methyl]-4-oxo-4-[[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butan-2-yl] 3-acetyloxy-2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanoate
(3s)-3-[(2r,3r,4s,5r,6r)-4-{[(2r,4s,5s,6s)-5-[(1s)-1-(acetyloxy)ethyl]-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-[(acetyloxy)methyl]-3-hydroxy-5-{[(2e)-2-isothiocyanatobut-2-enoyl]oxy}oxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
C31H40N2O17S (744.2047590000001)
2-[(4,5-dihydroxy-6-{[7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
[(1r,2r,7r,10s,14r,15r,16s,17r,18s,19s,20r)-18,19,20-tris(acetyloxy)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-7,12,17-trimethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁴,¹⁷.0¹,¹⁰.0²,⁷.0¹⁰,¹⁵.0¹⁴,¹⁹]docosan-15-yl]methyl acetate
2-{[8-(4-hydroxy-3,5-dimethoxyphenyl)-6-(hydroxymethyl)-1,3-dimethoxy-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (2s)-2-(acetyloxy)-2-[(1r,2r,6s,7s,8s,10s,12s,14s,15r,16s,17r,18r,19r,20r)-8,18,20-tris(acetyloxy)-6-(furan-3-yl)-7,12,15,17-tetramethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁴,¹⁷.0¹,¹⁰.0²,⁷.0¹⁰,¹⁵.0¹⁴,¹⁹]docosan-16-yl]acetate
methyl (2s)-2-(acetyloxy)-2-[(1r,2r,6s,7s,8s,10s,12s,14s,15r,16s,17r,18r,19s,20r)-8,18,20-tris(acetyloxy)-6-(furan-3-yl)-7,12,15,17-tetramethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁴,¹⁷.0¹,¹⁰.0²,⁷.0¹⁰,¹⁵.0¹⁴,¹⁹]docosan-16-yl]acetate
methyl 5-[2-(acetyloxy)ethylidene]-6-{[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-{2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl}-4,6-dihydropyran-3-carboxylate
3-[4-({5-[1-(acetyloxy)ethyl]-5-hydroxy-4-methoxy-6-methyloxan-2-yl}oxy)-6-[(acetyloxy)methyl]-3-hydroxy-5-[(2-isothiocyanatobut-2-enoyl)oxy]oxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
C31H40N2O17S (744.2047590000001)
(2s,3r,4s,5s,6r)-2-{[(6r,7r,8s)-8-(4-hydroxy-3,5-dimethoxyphenyl)-6-(hydroxymethyl)-1,3-dimethoxy-7-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl (2s,3ar,4r,4's,5'r,6s,7ar)-4'-(benzoyloxy)-3a,4-dihydroxy-5'-methyl-3-oxo-tetrahydro-4h-spiro[1-benzofuran-2,2'-oxane]-6-carboxylate
{6-[(2-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dimethoxyoxan-3-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methyl acetate
(1s,4as,7as)-7-({[(2e)-3-[(2r,3s)-7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoyl]oxy}methyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
(5s)-5-[(2r,3r,4s,5r,6r)-4-{[(2r,4s,5s,6s)-5-[(1s)-1-(acetyloxy)ethyl]-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-[(acetyloxy)methyl]-3-hydroxy-5-{[(2e)-2-isothiocyanatobut-2-enoyl]oxy}oxan-2-yl]-2-amino-5-hydroxy-3,6-dioxocyclohex-1-ene-1-carboxylic acid
C31H40N2O17S (744.2047590000001)
(2s,3r,4s,5s,6r)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-{[(1s,2r,3r)-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (4s,5e,6s)-5-[2-(acetyloxy)ethylidene]-6-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-{2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl}-4,6-dihydropyran-3-carboxylate
4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl 4'-(benzoyloxy)-3a,4-dihydroxy-5'-methyl-3-oxo-tetrahydro-4h-spiro[1-benzofuran-2,2'-oxane]-6-carboxylate
(2s,3r,4s,5s,6r)-2-(4-{[(2s,3s,4s)-4-[(3,5-dimethoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-2-hydroxyoxolan-3-yl]methyl}-2,6-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(4s,5s,6r)-5-ethenyl-4-[(2e)-4-[(2s,3r)-3-ethenyl-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-4-yl]-1-oxobut-2-en-2-yl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid
[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4s,5r)-2-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dimethoxyoxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
methyl 2-(acetyloxy)-2-[8,18,20-tris(acetyloxy)-6-(furan-3-yl)-7,12,15,17-tetramethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁴,¹⁷.0¹,¹⁰.0²,⁷.0¹⁰,¹⁵.0¹⁴,¹⁹]docosan-16-yl]acetate
(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl (2s,3ar,4s,4's,5'r,6s,7ar)-4'-(benzoyloxy)-3a,4-dihydroxy-5'-methyl-3-oxo-tetrahydro-4h-spiro[1-benzofuran-2,2'-oxane]-6-carboxylate
(4r,5r,6s)-5-ethenyl-4-[(2e)-4-[(2s,3r,4s)-3-ethenyl-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-4-yl]-1-oxobut-2-en-2-yl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid
2-(4-{4-[(3,5-dimethoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl}-2,6-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(4s,5s,6r)-5-ethenyl-4-[(2e)-4-[(2s,3r,4s)-3-ethenyl-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-4-yl]-1-oxobut-2-en-2-yl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid
5-[4-({5-[1-(acetyloxy)ethyl]-5-hydroxy-4-methoxy-6-methyloxan-2-yl}oxy)-6-[(acetyloxy)methyl]-3-hydroxy-5-{[(2z)-2-isothiocyanatobut-2-enoyl]oxy}oxan-2-yl]-2-amino-5-hydroxy-3,6-dioxocyclohex-1-ene-1-carboxylic acid
C31H40N2O17S (744.2047590000001)